Salix Pharmaceuticals, Ltd. Share Price

Stocks

17/03/15	Endo : Valeant trumps Endo with $10.96 billion bid for Salix Pharma	RE
16/03/15	Bank of Montreal : TSX climbs on upbeat sentiment ahead of Fed meeting	RE
16/03/15	Wall St. bounces as dollar drops, Fed worries ease	RE
16/03/15	Endo : withdraws offer for Salix	RE
11/03/15	Valeant Pharmaceuticals Intl : TSX rebounds as energy shares advance with oil price	RE
05/03/15	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
05/03/15	AbbVie : Biotech buys get pharma M&A off to flying start in 2015	RE
05/03/15	AbbVie : boosts cancer drug pipeline with $21 billion Pharmacyclics deal	RE
24/02/15	Shire : buys Meritage Pharma for at least $70 million	RE
23/02/15	Canadian Natural Resources : TSX gains on Valeant news; financial stocks weigh	RE
23/02/15	Boeing : Nasdaq ends up 9th session; S&P 500, Dow dip with energy	RE
23/02/15	BioMarin Pharmaceutical : Exclusive - Rare disease drugmaker PTC Therapeutics explores sale: sources	RE
21/02/15	Salix Pharmaceuticals : Valeant nears deal to buy Salix for about $10 billion - WSJ	RE

11/03/15	Salix Pharmaceuticals : Confirms Receipt of an Unsolicited Proposal from Endo International plc	BU
02/03/15	Salix Pharmaceuticals : Reports 4Q2014 and FY2014 Results	BU
27/02/15	Salix Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
25/02/15	Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2019	BU
25/02/15	Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due 2015	BU

01/04/15	Valeant Pharmaceuticals Intl : Le laboratoire canadien Valeant conclut l'acquisition de Salix
30/03/15	Sanofi ne juge pas des acquisitions "indispensables"-Pdt
16/03/15	Le recul du dollar a favorisé le rebond de Wall Street
16/03/15	Allergan : Valeant relève son offre sur Salix, Endo jette l'éponge
16/03/15	BlackBerry : Les valeurs à suivre sur les marchés américains

Manager	Title	Age	Since
Josh Coyle SAM	Sales & Marketing	-	31/12/2017
John Temperato SAM	Sales & Marketing	61	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SALIX PHARMACEUTICALS, LTD.	-.--%	+0.16%	-	-	0
MERCK & CO., INC.	-0.80%	-2.75%	+76.36%	+34.88%	366B
MERCK KGAA	+0.11%	+1.67%	+29.50%	-14.59%	70.76B
HALOZYME THERAPEUTICS, INC.	-1.47%	-2.61%	+44.02%	+144.43%	11.96B
KYOWA KIRIN CO., LTD.	+1.74%	+3.38%	+4.66%	+0.32%	8.72B
SK BIOPHARMACEUTICALS CO., LTD.	0.00%	+5.14%	-10.75%	+2.56%	5B
YUHAN CORPORATION	+2.66%	+3.16%	-25.20%	+22.62%	4.59B
BETTA PHARMACEUTICALS CO., LTD.	-1.79%	-1.23%	-28.47%	+3.73%	3.16B
SUPERNUS PHARMACEUTICALS, INC.	-1.04%	-4.62%	-3.08%	+38.12%	2.54B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-5.18%	-1.51%	-16.06%	-11.49%	2.08B
Average	-0.58%	+0.38%	+7.89%	+24.51%	52.76B
Weighted average by Cap.	-0.62%	-1.84%	+63.81%	+28.78%

Employees

Sector